Impact of the COVID-19 Pandemic on the Epidemiological Situation of Pulmonary Tuberculosis-Using Natural Language Processing

BACKGROUND: We aimed to analyze the impact of the COVID-19 pandemic on pulmonary tuberculosis (TB) using artificial intelligence. To do so, we compared the real-life situation during the pandemic with the pre-2020 situation.

METHODS: This non-interventional, retrospective, observational study applied natural language processing to the electronic health records of the Castilla-La Mancha region of Spain. The analysis was conducted from January 2015 to December 2020.

RESULTS: A total of 2592 patients were diagnosed with pulmonary tuberculosis; 64.6% were males, and the mean age was 53.5 years (95%CI 53.0-54.0). In 2020, pulmonary tuberculosis diagnoses dropped by 28% compared to 2019. In total, 62 (14.2%) patients were diagnosed with COVID-19 and pulmonary tuberculosis coinfection in 2020, with a mean age of 52.3 years (95%CI 48.3-56.2). The main symptoms in these patients were dyspnea (27.4%) and cough (35.5%), although their comorbidities were no greater than patients with isolated TB. The female sex was more frequently affected, representing 53.4% of this patient subgroup.

CONCLUSIONS: During the first year of the COVID-19 pandemic, a decrease was observed in the incidence of pulmonary tuberculosis. Women presented a significantly higher risk for pulmonary tuberculosis and COVID-19 coinfection, although the symptoms were not more severe than patients diagnosed with pulmonary tuberculosis alone.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Journal of personalized medicine - 13(2023), 12 vom: 22. Nov.

Sprache:

Englisch

Beteiligte Personen:

Morena, Diego [VerfasserIn]
Campos, Carolina [VerfasserIn]
Castillo, María [VerfasserIn]
Alonso, Miguel [VerfasserIn]
Benavent, María [VerfasserIn]
Izquierdo, José Luis [VerfasserIn]

Links:

Volltext

Themen:

Artificial intelligence
COVID-19
Journal Article
Pulmonary tuberculosis

Anmerkungen:

Date Revised 25.12.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/jpm13121629

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366295225